nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Methotrexate—colon cancer	0.212	0.422	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—colon cancer	0.123	0.245	CbGbCtD
Doxycycline—SLC22A6—Methotrexate—colon cancer	0.0859	0.171	CbGbCtD
Doxycycline—CYP3A4—Irinotecan—colon cancer	0.0433	0.0862	CbGbCtD
Doxycycline—CYP3A4—Vincristine—colon cancer	0.0379	0.0754	CbGbCtD
Doxycycline—MMP1—endothelium—colon cancer	0.0227	0.0933	CbGeAlD
Doxycycline—MMP7—gall bladder—colon cancer	0.0223	0.0918	CbGeAlD
Doxycycline—MMP1—blood vessel—colon cancer	0.0209	0.0861	CbGeAlD
Doxycycline—MMP7—epithelium—colon cancer	0.0115	0.0475	CbGeAlD
Doxycycline—MMP13—digestive system—colon cancer	0.011	0.0453	CbGeAlD
Doxycycline—MMP7—renal system—colon cancer	0.0107	0.044	CbGeAlD
Doxycycline—MMP1—epithelium—colon cancer	0.0102	0.0419	CbGeAlD
Doxycycline—MMP8—lymphoid tissue—colon cancer	0.0101	0.0414	CbGeAlD
Doxycycline—MMP8—digestive system—colon cancer	0.00994	0.0409	CbGeAlD
Doxycycline—MMP1—smooth muscle tissue—colon cancer	0.00982	0.0404	CbGeAlD
Doxycycline—MMP13—vagina—colon cancer	0.00974	0.04	CbGeAlD
Doxycycline—Minocycline—CASP3—colon cancer	0.00957	0.683	CrCbGaD
Doxycycline—MMP1—renal system—colon cancer	0.00945	0.0389	CbGeAlD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00918	0.0382	CbGpPWpGaD
Doxycycline—MMP8—bone marrow—colon cancer	0.00917	0.0377	CbGeAlD
Doxycycline—MMP7—lymphoid tissue—colon cancer	0.00889	0.0366	CbGeAlD
Doxycycline—MMP7—digestive system—colon cancer	0.00878	0.0361	CbGeAlD
Doxycycline—MMP1—Integrated Cancer Pathway—MSH6—colon cancer	0.00812	0.0338	CbGpPWpGaD
Doxycycline—MMP1—lymphoid tissue—colon cancer	0.00785	0.0323	CbGeAlD
Doxycycline—MMP7—vagina—colon cancer	0.00776	0.0319	CbGeAlD
Doxycycline—MMP1—digestive system—colon cancer	0.00775	0.0319	CbGeAlD
Doxycycline—MMP1—vagina—colon cancer	0.00685	0.0282	CbGeAlD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—AXIN2—colon cancer	0.00684	0.0285	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MSH2—colon cancer	0.00659	0.0274	CbGpPWpGaD
Doxycycline—SLC22A11—renal system—colon cancer	0.00599	0.0246	CbGeAlD
Doxycycline—MMP8—lymph node—colon cancer	0.00568	0.0234	CbGeAlD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00556	0.0232	CbGpPWpGaD
Doxycycline—SLC22A11—digestive system—colon cancer	0.00492	0.0202	CbGeAlD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—colon cancer	0.00485	0.0202	CbGpPWpGaD
Doxycycline—Minocycline—VEGFA—colon cancer	0.00445	0.317	CrCbGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—FGFR3—colon cancer	0.00435	0.0181	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—FGFR3—colon cancer	0.0041	0.0171	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.00382	0.0159	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—BAX—colon cancer	0.00373	0.0155	CbGpPWpGaD
Doxycycline—SLC22A11—liver—colon cancer	0.00366	0.0151	CbGeAlD
Doxycycline—MMP1—Bladder Cancer—BRAF—colon cancer	0.00353	0.0147	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—FGFR3—colon cancer	0.00348	0.0145	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDH1—colon cancer	0.00346	0.0144	CbGpPWpGaD
Doxycycline—SLC22A8—renal system—colon cancer	0.00338	0.0139	CbGeAlD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—colon cancer	0.00305	0.0127	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00303	0.0126	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—FGFR3—colon cancer	0.00297	0.0124	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CDH1—colon cancer	0.00264	0.011	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CCND1—colon cancer	0.00258	0.0107	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN1A—colon cancer	0.0025	0.0104	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00246	0.0102	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—colon cancer	0.00235	0.00977	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—colon cancer	0.00234	0.00973	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—BAX—colon cancer	0.00227	0.00944	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—colon cancer	0.00225	0.00938	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—colon cancer	0.00225	0.00937	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—colon cancer	0.00224	0.00933	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—TGFB1—colon cancer	0.00219	0.00914	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—colon cancer	0.0021	0.00873	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MYC—colon cancer	0.00207	0.00862	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—colon cancer	0.00206	0.00858	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—colon cancer	0.00206	0.00856	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—SRC—colon cancer	0.00204	0.00848	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—colon cancer	0.00202	0.00843	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CASP3—colon cancer	0.00202	0.00843	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CASP3—colon cancer	0.002	0.00834	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CDH1—colon cancer	0.00193	0.00803	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CASP3—colon cancer	0.0019	0.00791	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1A—colon cancer	0.00189	0.00785	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—CASP3—colon cancer	0.00187	0.00781	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CDH1—colon cancer	0.00186	0.00775	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—APC—colon cancer	0.00181	0.00755	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—CASP3—colon cancer	0.00181	0.00754	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—colon cancer	0.00178	0.00743	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—TGFB1—colon cancer	0.00175	0.0073	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—CASP3—colon cancer	0.00175	0.00728	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—colon cancer	0.0017	0.00708	CbGpPWpGaD
Doxycycline—CYP3A4—renal system—colon cancer	0.00168	0.00689	CbGeAlD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—SRC—colon cancer	0.00165	0.00689	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—SRC—colon cancer	0.00163	0.0068	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—colon cancer	0.00163	0.00679	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—HRAS—colon cancer	0.00162	0.00677	CbGpPWpGaD
Doxycycline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00161	0.00672	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—colon cancer	0.00161	0.00671	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—SRC—colon cancer	0.00158	0.00657	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MYC—colon cancer	0.00156	0.00651	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—colon cancer	0.0015	0.00623	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CDH1—colon cancer	0.00149	0.0062	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CASP3—colon cancer	0.00148	0.00615	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CASP3—colon cancer	0.00147	0.0061	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—colon cancer	0.00143	0.00597	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—colon cancer	0.00143	0.00596	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CASP3—colon cancer	0.00143	0.00594	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00139	0.00579	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—colon cancer	0.00138	0.00576	CbGpPWpGaD
Doxycycline—CYP3A4—digestive system—colon cancer	0.00137	0.00565	CbGeAlD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—KRAS—colon cancer	0.00137	0.0057	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCND1—colon cancer	0.00134	0.0056	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CTNNB1—colon cancer	0.00133	0.00554	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—SRC—colon cancer	0.00131	0.00545	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—colon cancer	0.00128	0.00535	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—SRC—colon cancer	0.00128	0.00532	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CCND1—colon cancer	0.00124	0.00518	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—colon cancer	0.00124	0.00518	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EP300—colon cancer	0.00124	0.00515	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CTNNB1—colon cancer	0.00123	0.00513	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—colon cancer	0.00122	0.00507	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—HRAS—colon cancer	0.00116	0.00485	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—PIK3CA—colon cancer	0.00116	0.00482	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.00115	0.00477	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—EP300—colon cancer	0.00115	0.00477	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CASP3—colon cancer	0.00114	0.00475	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.00113	0.00469	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—colon cancer	0.00112	0.00467	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CDH1—colon cancer	0.00111	0.00461	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CDX2—colon cancer	0.00109	0.00455	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—EP300—colon cancer	0.00109	0.00454	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—AKT1—colon cancer	0.00108	0.00452	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MYC—colon cancer	0.00108	0.00449	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—colon cancer	0.00108	0.00448	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—KRAS—colon cancer	0.00106	0.0044	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—AKT1—colon cancer	0.00104	0.00433	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—AKT1—colon cancer	0.00103	0.00428	CbGpPWpGaD
Doxycycline—CYP3A4—liver—colon cancer	0.00102	0.00421	CbGeAlD
Doxycycline—MMP13—AGE/RAGE pathway—AKT1—colon cancer	0.00102	0.00423	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—MYC—colon cancer	0.000998	0.00416	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000996	0.00415	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—AKT1—colon cancer	0.00098	0.00408	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000975	0.00406	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—AKT1—colon cancer	0.000946	0.00394	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—colon cancer	0.00094	0.00391	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MUC2—colon cancer	0.000929	0.00387	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—HRAS—colon cancer	0.000921	0.00384	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—SRC—colon cancer	0.000912	0.0038	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—HRAS—colon cancer	0.000899	0.00374	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—colon cancer	0.000886	0.00369	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000882	0.00367	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.000877	0.00365	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CASP3—colon cancer	0.000848	0.00353	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—colon cancer	0.00082	0.00341	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—AKT1—colon cancer	0.000814	0.00339	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CCND1—colon cancer	0.000809	0.00337	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CDH1—colon cancer	0.000808	0.00336	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—AKT1—colon cancer	0.000793	0.0033	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CDKN1A—colon cancer	0.000783	0.00326	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.00078	0.00325	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CDH1—colon cancer	0.00078	0.00325	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—KRAS—colon cancer	0.000755	0.00314	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000747	0.00311	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—EP300—colon cancer	0.000745	0.0031	CbGpPWpGaD
Doxycycline—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000743	0.00309	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000727	0.00303	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—SRC—colon cancer	0.000724	0.00302	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.00072	0.003	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	0.000694	0.00289	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000669	0.00279	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—colon cancer	0.00066	0.00275	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	0.000659	0.00274	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MYC—colon cancer	0.000649	0.0027	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—colon cancer	0.000648	0.0027	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—HRAS—colon cancer	0.000642	0.00267	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000634	0.00264	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CDH1—colon cancer	0.000624	0.0026	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CASP3—colon cancer	0.000618	0.00258	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CASP3—colon cancer	0.000597	0.00249	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000583	0.00243	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.00057	0.00237	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000539	0.00224	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—colon cancer	0.000533	0.00222	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000532	0.00222	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000517	0.00215	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000507	0.00211	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—colon cancer	0.000482	0.00201	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000479	0.00199	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CASP3—colon cancer	0.000478	0.00199	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—colon cancer	0.000465	0.00194	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—AKT1—colon cancer	0.00045	0.00188	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000404	0.00168	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—colon cancer	0.000372	0.00155	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000353	0.00147	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000283	0.00118	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EP300—colon cancer	0.000254	0.00106	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SRC—colon cancer	0.000247	0.00103	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—colon cancer	0.000241	0.001	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NRAS—colon cancer	0.000238	0.000991	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—colon cancer	0.000221	0.000921	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000216	0.0009	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CTNNB1—colon cancer	0.000215	0.000896	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—KRAS—colon cancer	0.000205	0.000853	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CA—colon cancer	0.000188	0.000783	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—colon cancer	0.000182	0.000758	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00018	0.000751	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—HRAS—colon cancer	0.000174	0.000725	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—AKT1—colon cancer	0.000154	0.00064	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA7—colon cancer	0.000148	0.000616	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ODC1—colon cancer	8.96e-05	0.000373	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CHST5—colon cancer	8.96e-05	0.000373	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCB1—colon cancer	2.37e-05	9.87e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMS—colon cancer	2.33e-05	9.69e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARG—colon cancer	1.65e-05	6.86e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—colon cancer	1.3e-05	5.4e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—EP300—colon cancer	1.08e-05	4.49e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CA—colon cancer	7.98e-06	3.32e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AKT1—colon cancer	6.52e-06	2.71e-05	CbGpPWpGaD
